T2 Biosystems, Inc.

0.0050-0.01 (-54.5%)

Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · TTOO · USD

Upcoming Earnings

Report date

≈ -

Key Stats

Market Cap

140.23K

P/E (TTM)

Basic EPS (TTM)

-0.03

Dividend Yield

Recent Filings

8-K

4/7/25Apr 7, 2025

8-K

2/20/25Feb 20, 2025

8-K

2/14/25Feb 14, 2025

8-K

2/11/25Feb 11, 2025

8-K

1/17/25Jan 17, 2025

About

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

CEO

Mr. Craig R. Jalbert CIRA

IPO

8/7/2014

Website

https://investors.t2biosystems.com

Employees

113

Sector

Healthcare

Industry

Diagnostics & Research